@FierceBiotech: NeuroPhage banks $6.4M for Alzheimer's drug development effort. Item | Follow @FierceBiotech
@JohnCFierce: AbbVie gains inside "breakthrough" track at FDA for hot hep C combo. News | Follow @JohnCFierce
@RyanMFierce: NeuroPhage found $6.4m for work on lead Alzheimer's candidate. Corporates Shire and Merieux invested. Release | Follow @RyanMFierce
> Cambridge, MA-based bluebird bio named Wendy Dixon, Ph.D., and David Schenkein, M.D., to the company's board of directors. Release
> Supernus Pharmaceuticals ($SUPN) issued $90 million worth of convertible notes in a private offering. Much of the money is intended for commercialization efforts. Release
> The Los Angeles Times takes a look at Amgen's ($AMGN) late-stage R&D plan as pressure builds to gain new approvals. Story
Pharma News
@FiercePharma: J&J issue in South Korea reminiscent of OTC problems here: Ordered to halt production of recalled Children's Tylenol: More | Follow @FiercePharma
@EricPFierce: Medicare spending growth so slow that Independent Payment Board won't be in play for 2015 drug pricing. Item | Follow @EricPFierce
> Covidien predicts up to 11% sales growth at soon-to-be independent Mallinckrodt unit. Report
> Merck wins FDA nod for new Zetia-Lipitor combo, despite lack of outcomes benefit. Story
> Pfizer combats online fakes with direct-to-patient Viagra sales. Article
@FierceMedDev: India draws industry ire with stent reimbursement reduction. Article | Follow @FierceMedDev
@MarkHFierce: Some VC love has gone to a Spanish diagnostics start-up, to the tune of $22.1 million. Release | Follow @MarkHFierce
@DamianFierce: Parexel is spending $24M to bolster its consulting services and predicting a strong 2013. Story | Follow @DamianFierce
> Florida sales tax exemption aids medical device manufacturing base. Item
> Medtronic wins FDA nods for next-gen cardiac devices. News
> Nose neurons offer scent of schizophrenia Dx possibility. DxExtra
CRO News
> Welsh CRO Simbec goes independent with new investment. Item
> CRO Novotech picks up PE investment to expand in Asia. News
> TFS buys Beardsworth to expand oncology trial work. Article
> Covance dials up projections after strong Q1. More
Biotech IT News
> Doc launches user-friendly website for clinical trials searches. More
> Martin Leach's 16-year interview for the job of Big Data boss at Biogen Idec. Editor's corner
> IMS Health acquires social media analytics startup Semantelli. Report
> Comprehend, GNS reach milestones with software for drug researchers. Article
> Sanofi teams with Big Data outfit to research drugs for diabetes and cancer. Story
And Finally… A European team of investigators say they've come up with a new treatment for a common sign of aging: gray hair. Release